h2o Announces FDA Listing of Apple Watch-Based Cueing Feature ‘Foggy’ for Freezing of Gait in Parkinson’s Disease
The innovative new feature within the Parky app for Apple Watch is available by prescription for people with Parkinson’s disease. h2o therapeutics today announced that...
Stem Cell Therapy Developed in Korea Begins Treatment for Parkinson’s Disease Patients Worldwide in Japan
Biostar Stem Cell Research Institute has received approval from Japan's Ministry of Health, Labor and Welfare to Treat Parkinson's Disease. The combination of intravenous and...
Core One’s Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer’s and Parkinson’s Disease
VANCOUVER, BC / ACCESSWIRE / August 4, 2023 / Core One Labs Inc. (CSE:COOL) (OTCQB:CLABF) (Frankfurt:LD6, WKN:A3CSSU), (the "Company" or "Core One") is delighted to...
Early Announcement of Significantly Beneficial Clinical Trial Evidence From Young Blood Plasma Treatments
Investigational young Fresh Frozen Plasma (yFFP®) Treatments Study YP042022 IRCM-2022-333 Golden Gift, a 501(c)(3) nonprofit organization in support of the therapeutic use of blood plasma...
Coming Together on the Journey to End Parkinson’s
AbbottNORTHAMPTON, MA / ACCESSWIRE / May 19, 2023 / As far as epic journeys go, 1.2 miles is pretty manageable and quite lovely.New York's Central...
h2o Therapeutics Announces Collaboration With AmerisourceBergen to Support the Commercialization of Apple Watch-Based App Parky for Parkinson’s Disease
Digital health start-up h2o Therapeutics today announced a collaboration with global healthcare company AmerisourceBergen to support the commercialization of Parky, a prescription mobile app cleared...
Using Whole-Genome Sequencing To Study Early-Onset Parkinson’s Disease
NORTHAMPTON, MA / ACCESSWIRE / February 15, 2023 / Illumina:Originally published on Illumina News CenterThe Norwegian term for virgin snow, "nysnø", seemed the appropriate inspiration...